Yoko Bian

ID: 1b83acd4-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Alvotech Broadens Access to HUMIRA (adalimumab) Biosimilars

Big Molecule Watch · December 8, 2022

AbbVie’s Q322 Earnings Call Highlights Oncoming Adalimumab Biosimilar Competition

Big Molecule Watch · November 3, 2022

EMA Adopts Positive Opinion for STADA and Xbrane’s Ranibuzumab Biosimilar Candidate XIMLUCI®

Big Molecule Watch · September 28, 2022

Alvotech Initiates Confirmatory Patient Study for AVT03, a Proposed Denosumab Biosimilar

Big Molecule Watch · August 26, 2022

FDA Workshop on Sept. 19, 2022: Increasing the Efficiency of Biosimilar Development Programs

Big Molecule Watch · August 23, 2022